Skip to main content

Table 1 Characteristics of population by CTF cases and control status

From: Inflammation and micronutrient biomarkers predict clinical HIV treatment failure and incident active TB in HIV-infected adults: a case-control study

Characteristic

All

n = 290

CTF

n = 124 (43%)

Controls

n = 166 (57%)

p valuea

Gender

 Male

160 (55)

71 (44)

89 (56)

0.55

 Female

130 (45)

53 (41)

77 (59)

 

Age (years)

35.0 (29.0–42.0)

35.5 (29.5–42.0)

35.0 (29.0–42.0)

0.81

Country

 Brazil

44 (15)

16 (36)

28 (64)

0.001

 Haiti

34 (12)

11 (32)

23 (68)

 

 India

23 (8)

18 (78)

5 (22)

 

 Malawi

38 (13)

22 (58)

16 (42)

 

 Peru

19 (7)

4 (21)

15 (79)

 

 South Africa

38 (13)

20 (53)

18 (47)

 

 Thailand

23 (8)

6 (26)

17 (74)

 

 USA

44 (15)

17 (39)

27 (61)

 

 Zimbabwe

27 (9)

10 (37)

17 (63)

 

Body mass index (kg/m2)

 < 18.5

29 (10)

18 (62)

11 (38)

0.001

 18–25

192 (66)

89 (46)

103 (54)

 

 ≥ 25

69 (24)

17 (25)

52 (75)

 

Prior TB diagnosis

 Yes

59 (20)

34 (58)

25 (42)

0.01

 No

231 (80)

90 (39)

141 (61)

 

Treatment arm

 A

100 (35)

58 (56)

45 (44)

0.72

 B

108 (37)

54 (42)

39 (58)

 C

82 (28)

67 (29)

27 (71)

CD4 count (cells/mm3)

 < 100

103 (36)

50 (69)

22 (31)

< 0.001

 100–200

93 (32)

45 (49)

46 (51)

 

 > 200

94 (34)

43 (41)

63 (59)

 

Log viral load (copies/mL)

 < 4

21 (7)

6 (29)

15 (71)

0.18

 4–5

98 (34)

38 (39)

60 (61)

 

 > 5

171 (59)

80 (47)

91 (53)

 

Hypoalbuminemia

 Yes (≤ 3.5 g/dL)

77 (19)

51 (41)

26 (16)

< 0.001

 No (> 3.5 g/dL)

215 (81)

73 (59)

140 (84)

 

Anemia

 Yes

168 (58)

87 (54)

81 (46)

< 0.001

 No

121 (42)

36 (50)

85 (50)

 
  1. Data are presented as number (%) of the CTF case control. Anemia is defined based on hemoglobin cutoffs for males (< 13.0 g/dL) and non-pregnant females (< 12.0 g/dL). aFisher’s exact test was used to calculate the p values for categorical variables, and the rank sum test for continuous variables